Ansell | ANN - Ebitda

股票价格

26.37

每天变化

0.05 0.19%

每月一次

-6.59%

每年

-14.66%

Q2 预测

26.26

金融业

USD

USD 3.33B

现金及等价物

USD 238.3M

USD 605.3M

USD 1.11B

USD 468.9M

USD 805.6M

股息收益率

USD 2.15

USD 146.5M

USD 185.8M

USD 15.72K

EPS每股收益

USD 0.66

股本和储备

USD 1.97B

USD 326.2M

债务利息支出

USD 20.6M

USD 2.6M

USD 751.6M

USD 3.82B

USD 88.8M

USD 880.1M

USD 146.5M

普通股股本

USD 142.94M

15.12

USD 33.35M

USD 1.03B

销售和管理费用

USD 274.8M

USD 584.7M

贸易债权人

USD 302.3M

应收帐款人

USD 231.1M

	Ebitda	更改		日
Amotiv	AUD 116.1M		4.6M	2025-12
Ansell	USD 185.8M		7M	2025-12
Cochlear	AUD 306.4M		13.5M	2025-12
CSL	USD 3.13B		1.17B	2025-12
Fisher Paykel Healthcare	NZD 364M		78.5M	2025-06
Healius	AUD 74.9M		40.3M	2025-06
Integral Diagnostics	AUD 46.27M		3.52M	2024-06
Mayne Pharma	AUD 20.9M		5.2M	2025-06
Nanosonics	AUD 12.49M		1.13M	2025-12
Polynovo	AUD 3.89M		100K	2025-12
Ramsay Health Care	AUD 1.12B		10.6M	2025-12
Regis Healthcare	AUD 70.59M		12.81M	2025-12
ResMed	USD 547.48M		27.46M	2025-12
Sigma Healthcare	AUD 19.96M		5.15M	2024-07
Somnomed	AUD 764.45K		479.23K	2023-06
Sonic Healthcare	AUD 839.07M		51.09M	2024-12